ABBV-706
Immunology
Phase 1Active
Key Facts
About AbbVie
AbbVie's mission is to discover and deliver transformative medicines that solve serious health issues. Its landmark achievement was building the world's top-selling drug, Humira, into a franchise while successfully navigating its patent expiry through a robust pipeline and strategic acquisitions like Allergan. The company's strategy hinges on sustained leadership in immunology, accelerated growth in oncology and neuroscience, and financial discipline to fuel high R&D investment and shareholder returns.
View full company profileTherapeutic Areas
Other Immunology Drugs
| Drug | Company | Phase |
|---|---|---|
| Biosimilars Pipeline (Immunology Focus) | Aurobindo Pharma | Development |